Underlying medical contraindications: Your doctor will ensure GLP-1s are safe for you based on your personal and family history
mutations in OCTN2 lead to primary carnitine deficiency (PCD), a disorder characterized by systemic carnitine depletion and associated clinical manifestations, including muscle weakness, cardiomyopathy, and infertility
The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties
After the run-in period on pioglitazone monotherapy, patients with inadequate glycemic control (A1C 7% to 10%) were randomized to the addition of either 100 mg of JANUVIA or placebo, administered once daily
FDA concluded in 2026 that evidence was insufficient to support wound-healing effectiveness
We note the proposed APC assignments and status indicators for these same codes will be subject to comment in the CY 2027 OPPS/ASC proposed rule with comment period and will be finalized in the CY 2027 OPPS/ASC final rule with comment period